The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions

被引：0
|
作者：
Afshar-Oromieh, A. [1 ]
Hetzheim, H. [2 ]
Kratochwil, C. [1 ]
Benesova, M. [3 ]
Eder, M. [4 ]
Neels, O.
Kuebler, W. [5 ]
Giesel, F. L. [1 ]
Mier, W. [6 ]
Kopka, K. [4 ]
Haberkorn, U. [1 ]
机构：
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany
[3] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[4] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[5] German Canc Res Ctr, Div Radiat Protect & Dosimetry, Heidelberg, Germany
[6] Univ Heidelberg Hosp, Div Radiochem, Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP429
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [1] The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
    Afshar-Oromieh, Ali
    Hetzheim, Henrik
    Kratochwil, Clemens
    Benesova, Martina
    Eder, Matthias
    Neels, Oliver C.
    Eisenhut, Michael
    Kuebler, Wolfgang
    Holland-Letz, Tim
    Giesel, Frederik L.
    Mier, Walter
    Kopka, Klaus
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (11) : 1697 - 1705
  • [2] The novel PSMA ligand DKFZ-617 in the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumor lesions
    Afshar-Oromieh, Ali
    Kratochwil, Clemens
    Benesova, Martina
    Eder, Matthias
    Kopka, Klaus
    Neels, Oliver
    Giesel, Frederik
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [3] Procedure Guideline for Prostate Cancer Imaging with PSMA-ligand PET/CT
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Fendler, Wolfgang
    Schmidt, Matthias
    Rahbar, Kambiz
    Ahmadzadehfar, Hojjat
    Umutlu, Lale
    Hadaschik, Boris
    Hakenberg, Oliver W.
    Fornara, Paolo
    Kurth, Jens
    Neels, O.
    Wester, Hans-Juergen
    Schwaiger, Markus
    Kopka, Klaus
    Haberkorn, Uwe
    Herrmann, Ken
    Krause, Bernd J.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2023, 62 (01): : 5 - 19
  • [4] PSMA-617-a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer
    Benesova, Martina
    Kratochwil, Clemens
    Schaefer, Martin
    Bauder-Wuest, Ulrike
    Afshar-Oromieh, Ali
    Mier, Walter
    Haberkorn, Uwe
    Kopka, Klaus
    Eder, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [5] PSMA-Ligand Uptake in Disseminated Epidermoid Cysts in a PSMA PET/CT of a Patient With Recurrent Prostate Cancer
    Bohn, Karl Peter
    Alberts, Ian
    Mingels, Clemens
    Rominger, Axel
    Afshar-Oromieh, Ali
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (12) : E598 - E599
  • [6] PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    A. Afshar-Oromieh
    A. Malcher
    M. Eder
    M. Eisenhut
    H. G. Linhart
    B. A. Hadaschik
    T. Holland-Letz
    F. L. Giesel
    C. Kratochwil
    S. Haufe
    U. Haberkorn
    C. M. Zechmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 486 - 495
  • [7] PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    Afshar-Oromieh, A.
    Malcher, A.
    Eder, M.
    Eisenhut, M.
    Linhart, H. G.
    Hadaschik, B. A.
    Holland-Letz, T.
    Giesel, F. L.
    Kratochwil, C.
    Haufe, S.
    Haberkorn, U.
    Zechmann, C. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 486 - 495
  • [8] Erratum to: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    A. Afshar-Oromieh
    A. Malcher
    M. Eder
    M. Eisenhut
    H. G. Linhart
    B. A. Hadaschik
    T. Holland-Letz
    F. L. Giesel
    C. Kratochwil
    S. Haufe
    U. Haberkorn
    C. M. Zechmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 797 - 798
  • [9] 89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man
    Bastiaan M. Privé
    Yvonne H. W. Derks
    Florian Rosar
    Gerben M. Franssen
    Steffie M. B. Peters
    Fadi Khreish
    Mark Bartholomä
    Stephan Maus
    Martin Gotthardt
    Peter Laverman
    Mark W. Konijnenberg
    Samer Ezziddin
    James Nagarajah
    Sandra Heskamp
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 2064 - 2076
  • [10] 89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man
    Prive, Bastiaan M.
    Derks, Yvonne H. W.
    Rosar, Florian
    Franssen, Gerben M.
    Peters, Steffie M. B.
    Khreish, Fadi
    Bartholomae, Mark
    Maus, Stephan
    Gotthardt, Martin
    Laverman, Peter
    Konijnenberg, Mark W.
    Ezziddin, Samer
    Nagarajah, James
    Heskamp, Sandra
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (06) : 2064 - 2076
12345